Intel is not a buy right now, says Bernstein's Stacy Rasgon
Stacy Rasgon, Bernstein managing director, joins 'The Exchange' to discuss Intel and what's behind the stocks big week.
The American Journal of Managed Care36m
Kansas City’s TB Outbreak Can Be Contained With the Lessons From COVID-19
In this final interview clip, Michael A. Bernstein, MD, stresses the need for effective communication and proactive screening ...
Bernstein raises Twilio stock price target to $119, maintains rating
Bernstein SocGen Group updated its outlook on Twilio (NYSE:TWLO), increasing the price target to $119 from the previous $82, while keeping a Market Perform rating on the shares. The stock currently ...
Intel’s (NASDAQ:INTC) Joint Venture Comes Under Fire
We have been following the potential new deal between chip stock Intel (INTC) and Taiwan Semiconductor (TSM) for the last few ...
Business Wire1d
Harvard Business Review Names Amy Bernstein Editor in Chief
Harvard Business Review has named Amy Bernstein, a veteran business journalist and longtime Editor of its bimonthly magazine, ...
Cloudflare price target raised to $100 from $80 at Bernstein
Bernstein raised the firm’s price target on Cloudflare (NET) to $100 from $80 and keeps a Market Perform rating on the shares ...
Bernstein Sticks to Its Buy Rating for On Holding AG (ONON)
Bernstein analyst Thierry Cota maintained a Buy rating on On Holding AG (ONON – Research Report) today and set a price target of $73.00. The ...
Biogen receives Market Perform rating at Bernstein ahead of earnings
Biogen (BIIB) stock was granted a Market Perform recommendation by Bernstein ahead of Q4 earnings, citing concerns over its Alzheimer's drug sales. Read more here.